SpaceX shares closed Thursday at approximately $78, marking a 42% decline from the post-IPO high and falling below the $135 debut price for the first time since the company's stock began trading on secondary platforms. The reversal accelerated following a last-second abort of the Starship Flight 8 test Thursday evening, which had been positioned by traders as a near-term catalyst for reversal.
The abort—triggered less than ten seconds before planned liftoff—came as SpaceX's secondary market liquidity remained thin, with bid-ask spreads widening to 8-12% on private placement platforms. Positioning data from Forge Global and EquityZen showed net seller interest climbing to a three-week high in the 48 hours preceding the scrubbed launch. The company has not issued new guidance on the next launch window, though internal engineering protocols typically allow for reattempts within 72-96 hours following telemetry-related aborts.
The price action reflects a liquidity event isolated to secondary markets, not primary capital structure. SpaceX remains privately held with no debt service pressure and a last formal valuation of $350 billion in December 2024 venture rounds. But the gap between that institutional pricing and current secondary trading levels signals allocator uncertainty around near-term operational milestones and the regulatory timeline for Starship's orbital certification. The Pentagon AI computing deal now in negotiation—a multi-billion-dollar data center capacity contract—has not stabilized liquidity, suggesting traders are pricing execution risk rather than contract optionality.
What allocators should watch: the next Starship launch attempt, expected within four to seven days if telemetry reviews confirm no hardware faults; any formal Pentagon contract announcement, which would clarify whether SpaceX is positioning Starlink infrastructure for defense AI workloads or building standalone facilities; and secondary market volume in the May 15-June 30 window, when early employees face the next quarterly liquidity event under the company's tender offer structure. If volume remains elevated and price action stays volatile, it may indicate insider sentiment has shifted on the Starship commercialization timeline.
The secondary market now prices SpaceX as if the Starship program is 18-24 months behind the internal schedule Musk outlined in March. That assumption may prove correct.